Innovations in eye care with Steven Schwartz, MD, and Sean Ianchulev, MD (Re-Release)
Click Here to Manage Email Alerts
In this special throwback episode, John Hovanesian, MD, and Jim Mazzo revisit their discussions with Steven Schwartz, MD, and Sean Ianculev, MD, about innovations, treatments and entrepreneurship in eye care.
- Welcome to the Eyeluminaries podcast :10
- About Steven Schwartz, MD 2:32
- The interview 3:16
- Discussion of current innovation in cataract surgery including use of AI, imaging and robotics 4:05
- Discussion on Schwartz’s involvement in Neurotech MacTel cell-based treatment 6:32
- Advances and disappointments in retinal disease treatments? 10:32
- How do companies come back from disappointing trial results? 11:07
- Why do retina discoveries take so long to develop? 14:31
- New dry AMD treatments in development? 15:58
- Drug delivery technologies and will retina specialists use them? 18:56
- What do you predict we’ll be doing differently in medicine 2 years from now and why? 22:00
- What’s the difference between a retina and cornea specialist? 23:52
- Introduction of Sean Ianchulev, MD, MPH 25:38
- The interview 26:29
- Impact on Google Glass 30:27
- What innovations are you proud of and what projects are you excited about? 35:31
- What advice do you have for new entrepreneurs? 42:16
- How do you balance your work life and your home life? 45:25
- Legends in the field of ophthalmology 47:39
- Give feedback at eyeluminaries@healio.com 49:36
- Thanks for listening 49:57
Sean Ianchulev, MD, MPH, is a Harvard-trained physician-scientist, a professor of ophthalmology and the head of innovation and technology at New York Eye and Ear Infirmary founder and chairman of Iantrek Inc and Eyenovia and serves as a board member for the American Society of Cataract and Refractive Surgery Foundation and AEYE Health.
John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California.
Jim Mazzo sits on numerous ophthalmic industry corporate boards and committees after serving in executive roles with Allergan, Avellino Labs, Carl Zeiss and AMO.
Steven Schwartz, MD, is the Ahmanson professor in ophthalmology and the chief of the retina division at the UCLA Jules Stein Eye Institute and the director of the Diabetic Eye Disease and Retinal Vascular Center.
We’d love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. You can reach Dr. Schwartz via email at schwartzpatients@jsei.ucla.edu. You can find Dr. Ianchulev on LinkedIn.
Collapse
Read more about
Click Here to Manage Email Alerts
